Tidewave Bio
Pre-clinicalScalable, universal cell therapy platform for solid tumors. Off-the-shelf immunotherapy personalized in real time, available at cancer centers nationwide.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $5M
About
Scalable, universal cell therapy platform for solid tumors. Off-the-shelf immunotherapy personalized in real time, available at cancer centers nationwide.
Cell & Gene Therapy
Funding History
1Total raised:$5M
Seed$5MJun 15, 2022